Peter Liu, MD
Ottawa Heart Institute Research Corporation
5
5
2
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Karen E Yeates, MD, FRCP(C), MPH
Queen's University
Shared therapeutic areas:
Worked with same sponsors:
Sheldon W Tobe, MD, MScCH (HPTE), FRCPC, FACP,
Sunnybrook Health Sciences Centre, University of Toronto
Shared therapeutic areas:
Worked with same sponsors:
Norman RC Campbell, MD, FRCPC
University of Calgary
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
David s Ludwig, MD, PhD
Boston Children's Hospital
Shared therapeutic areas:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Mikhail Samsonov
R-Pharm
Shared therapeutic areas:
Shirley Wang, PhD, ScM
Brigham and Women's Hospital
Shared therapeutic areas:
Xiaolong Qi, MD
LanZhou University
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
The COVID-RASi Trial (COVID-19)
Biomarker Guided Discharge of Heart Failure Patients
Sub-Clinical Atrial Fibrillation Biomarker Study
Detecting and Treating High Blood Pressure in Aboriginal Population and Low and Middle Income Countries
All 5 trials loaded